QualityStocks

[QualityStocks]

CD International Enterprises, Inc. (CDII) Exploiting Global Market Opportunities

With a wealth of experience and international distribution networks already in place, CD International Enterprises, Inc. (OTC: CDII) recently formed a new subsidiary and launched a new online store to maximize product delivery and penetrate a market of 2+ billion people.

For over a decade, CD International has sourced and distributed industrial commodities in China and the Americas. Headquartered in South Florida, the company has focused on international commodity sourcing and trading in iron ore, manganese ore, and scrap metals for companies located throughout the People’s Republic of China. To facilitate its commodity trading services, CD International also provides financing, logistics, quality control and legal and technical due diligence to its suppliers and purchasers. The company’s trading division naturally spawned CD International’s consultation services division to provide guidance for Chinese entities to compete in a complex global economy. The company’s background and know-how have given it the unique ability to identify and exploit emerging global market opportunities. In conjunction with its ongoing expansion initiative, CD International recently embarked upon a new enterprise to leverage its international experience and profit from the bulk distribution of medicinal cannabidiol (CBD) products in the U.S. and the sale of CBD-based products to the 2+ billion Chinese-speaking people located around the globe.

With the launch of its wholly-owned subsidiary, Green Products Distribution, and its online retail store (http://www.greencbdproducts.com/cbd), CD International is positioned to capture more than a fair share of this burgeoning market. With a projected annual growth rate north of 50 percent and the innate acceptance of holistic medicinal treatments in the Chinese culture, CD International fully expects this new enterprise to exceed expectations. The company’s expertise in international trade and its understanding of the vagaries of Chinese commerce give the company competitive advantages to exploit and capitalize on this fast developing global market.

A seemingly curious diversion from conventional business practices, the opportunity is just too great for the company not to engage. Chairman and CEO of CD International, Dr. James Wang, recently stated, “Research has indicated CBD to be effective in treating epilepsy, Alzheimer’s disease, cirrhosis of the liver and to provide relief from hangover, anxiety and stress. Because natural extract of CBD-based products is so similar to traditional Chinese medicine, management believes there is huge opportunity in Chinese-speaking communities for CBD-based products.”

Given the company’s track record in international business and its deep understanding of Chinese culture and practices, CD International’s latest foray is far from just a curious diversion.

For more information, visit the company’s website at www.CDII.net